Hypokinesia syndrome in the elderly and metabolic syndrome in diabetes increase the risk of chronic low-intensity neuroinflammation, leading to impaired neuro-immune-vascular regulation.

As a result, the following occur:
• Inflammatory pain.
• Disorders in the musculoskeletal system.
• Damage to the vessel walls affecting their elasticity.

The main component of Rutamid:
• Reduces inflammation.
• Improves vessel elasticity.
• In combination with hydroxytyrosol (an antioxidant from olive oil), helps control lipid levels.

How does it work?
Palmitoylethanolamide (PEA) supports normal reactivity of nerve tissue, reducing inflammatory and neuropathic pain.

Composition:
• Palmitoylethanolamide, rutin.
• Hydroxytyrosol.
• Microcrystalline cellulose, magnesium salts of fatty acids, stabilizers, anti-caking agents, colorants.

Nutritional value (per 1 tablet):
• Energy: 12.7 kJ / 3.0 kcal.
• Fats: 0.3 g (including saturated fats: 0.26 g).
• Carbohydrates: 0.084 g.
• Palmitoylethanolamide: 0.3 g.
• Rutin: 0.06 g.
• Hydroxytyrosol: 0.015 g.

Directions for use:
1–2 tablets per day as prescribed by a doctor.

Warnings:
• Use under medical supervision.
• Not suitable as the sole source of nutrition.
• Do not use during pregnancy.
• Keep out of reach of children.

Packaging: 90 tablets.